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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Hemangiopericytoma is a very rare orbital tumor. The purpose of this
study was to report the clinical and histopathological features of six cases of orbital hemangio-
pericytoma in an Asian population.
Methods: Clinical and histopathological features were reviewed in six patients who were histo-
pathologically confirmed as having primary orbital hemangiopericytoma in National Taiwan
University Hospital between May 2001 and December 2010.
Results: Among the six cases who were diagnosed as having primary orbital hemangiopericy-
toma, all lesions were reported as vascular tumors and featured branching “staghorn
appearance” vessels. All patients, including one male and five females, presented with
progressive proptosis and some associated symptoms such as extraocular motility limitation
with diplopia, displacement of the globe, afferent pupillary defect, congested vessels of
conjunctiva, or decreased visual acuity. On computed tomography, the orbital tumors
tended to manifest as circumscribed masses with homogeneous medium-to-high enhance-
ment with contrast studies. All six patients received surgical treatments, and four of them
had additional radiotherapy. Three patients had recurrence after surgeries, and one of them
had multiple metastases to lung and liver. All patients were still alive after a follow-up
period of 5e10 years.
Conclusion: Orbital hemangiopericytoma has malignant potential, which may lead to local
recurrence and/or metastasis. Histopathological findings alone are insufficient to predictauthors have any financial or proprietary interest in any materials or methods mentioned.
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Orbital hemangiopericytoma in an Asian population 357the behavior of this tumor. Therefore, both clinical and histopathological findings are impor-
tant to evaluate the treatment outcomes. Total excision accompanied with radiotherapy is
suggested and long-term follow-up is required.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Hemangiopericytoma, first described in 1942 as a distinct
vascular tumor of soft tissue, is a raremesenchymal neoplasm
originating from the pericytes of blood vessels.1 Pericytes are
mesodermal cells surrounding small blood vessels; therefore,
this tumor may develop wherever capillaries are present.
Although the incidence of this rare tumor in the head and
neck region is 16%, hemangiopericytomas originating in the
orbits account for less than 5%.2 In one of Shields’s series, the
incidence of this tumor accounts for only 1% of all orbital
biopsies and 4% of all orbital vascular tumors.3
Primary orbital hemangiopericytoma is a well-defined,
slowly growing mass. B-scan ultrasonography usually shows
this tumorasawell-delineated roundoroval lesionwith low to
medium internal reflectivity; the tumor is mostly irregular,
with solid and cystic components.4 On computed tomography
(CT) imaging, it is seen as a well-circumscribed mass occu-
pying either the extraconal or the intraconal space, which
intensely enhances with contrast.5,6 The definite diagnosis of
hemangiopericytoma must depend on pathological examina-
tion of the surgical specimen. The largest series of this orbital
neoplasm, a report of 30 cases, was conducted by Croxatto
and Font in 1982.5 However, within the past 15 years, the
largest study, reported in 1997 by Karcioglu et al,6 included
only seven patients. In Asia, only a few single-case reports
have ever been published.7,8 In this study, we present our
experience with six patients diagnosed with unilateral orbital
hemangiopericytomas within the last 10 years.Patients and methods
This retrospective study included six patients histopatho-
logically diagnosed as having orbital hemangiopericytomas
in National Taiwan University Hospital between May 2001
and December 2010. All lesions were reported as vascular
tumors with featured branching “staghorn appearance”
vessels. There were five females and one male, aged from
30 to 62 years, with a median of 44. Three patients had
right orbital involvement, while the others had left orbital
involvement. The duration of symptoms prior to initial visit
ranged from 5 months to 10 years, and the follow-up period
ranged from 5 to 10 years. Clinical data, and radiologic and
histopathological examinations were reviewed. Special
attention was paid to treatment modalities and clinical
outcomes after long-term follow-up. Local administrative
and ethics committees approved all aspects of this study.Results
Six patients, five females (aged 30e62 years; median 41
years) and one male (aged 53 years), were included in thisstudy. Initial presentations varied: two patients (Cases 3
and 4) presented as having palpable masses on their eyelids,
one patient (Case 1) as having eyelid swelling, one patient
(Case 5) as having eye protrusion, and two patients (Cases 2
and 6) complained loss of vision with best-corrected visual
acuity around counting fingers (CFs) 20 cm (Case 2) to light
perception (LP) (Case 6) (Table 1).
However, under thorough ophthalmic examinations, all
patients had unilateral proptosis ranging from 3 to 7 mm;
five had different degrees of extraocular muscle limitation
(Case 2e6) and therefore complained of double vision
(Cases 2e5). Blurring or loss of vision was an associated
symptom in four patients (Cases 2, 4e6), and visual acuity
was severely decreased to CF or LP level for three of them
(Case 2: CF 20 cm, Case 4: CF 50 cm, and Case 6: LP).
Visible protruding masses with conjunctival engorged
vessels were found in two patients (Cases 3 and 6)
(Table 1). All patients except one who had severe
displacement of globe and marked strabismus (Case 4)
(Fig. 1A) underwent indirect ophthalmoscopy examination.
A pigmented, mass-like lesion was noted on the retina in
Case 2. Papilloedema and retinal folds on the temporal
retina were evident on the fundus examination in Case 5,
who had the poorest visual acuity. In addition, these two
patients presented anisocoria without any evidence of
pupillary light reflex on the affected eye.
The results of imaging studies are shown in Table 1. Ultra-
sonography was performed only on the first two patients
(Cases 1 and 2): one of the tumors showed low-to-moderate
echogenicity (Case 2) (Fig. 2), while the other revealed
moderate-to-high echogenicity (Case 1). Initial CT for all
patients depicted orbital masses, and four of them were
superiorly located (Cases 1e3, 5) (Fig. 3A). Homogeneous
orbital mass lesion was noted in three cases (Cases 1e3), but
the other three lesionswereheterogeneous (Cases 4e6) (Figs.
1B and 3A). The tumors were all well enhanced with contrast
medium. Neither the central nervous system extension nor
any bony change has been found in all patients.
Differential diagnoses varied regarding these six tumors
after the initial clinical examinations and image studies
(Table 1). The diagnoses included hemangioma, lymphoma,
meningioma, pseudotumor, rhabdomyosarcoma, and glioma.
Hemangiopericytoma was considered among the initial list of
differential diagnoses only in one case even after CT was
completed.
Histopathological and immunochemical findings are
shown in Table 2. All lesions were reported as vascular
tumors and featured branching “staghorn appearance”
vessels (Figs. 3B and 4A). The proliferating pericytes in four
of the specimens had benign-looking patterns: two (Cases 1
and 2) were described as “bland cells” and other two (Cases
3 and 5) as “with low to occasional mitotic rates.” Only the
specimen for Patient 4 showing occasional necrosis and the
specimen for Patient 6 demonstrating frequent mitotic
Table 1 Summary of clinical and imaging findings.
No. Age,
sex,
orbit
Duration
before
diagnosis
Initial presentation Initial BCVA (R, L) Associated
symptoms
Computed tomography Initial differential diagnosis
1 30, F, R 2 y Upper eyelid swelling 20/20, 20/20 Eye protrusion / Location: anterosuperior
/ Enlargement of lacrimal gland
Lacrimal gland tumor
2 50, F, R 10 y Loss of vision CF 20 cm, 20/30 Eye protrusion
Double vision
/ Location: retrobulbar, posterosuperior
/ Round, homogeneous, well-enhanced
mass; eyeball displacement
Meningioma
Glioma
Hemangioma
Lymphoma
3 41, F, L 5 mo Upper eyelid mass 20/30, 20/25 Eye protrusion
Double vision
Subconjunctival mass
Conjunctival redness
/ Location: superior
/ Homogeneous extraconal mass,
displacement of the superior rectus
muscle and eyeball
Lymphoma
Lymphangioma
Pseudotumor
4 62, F, R 6 mo Lower eyelid mass CF 50 cm, 20/30 Double vision
Blurred vision
Eye protrusion
/ Location: retrobulbar, inferior
/ Heterogeneous, well-enhanced mass;
eyeball displacement; optic nerve
involvement
Hemangioma
Meningioma
Hemangiopericytoma
5 30, F, L 6 mo Eye protrusion 20/20, 20/60 Double vision
Blurred vision
/ Location: medial-superior
/ Intraconal well-enhanced mass; eyeball
is compressed
Hemangioma
6 50, M, L 6 mo Loss of vision 20/30, LP Eye protrusion
Conjunctival redness
/ Location: retrobulbar
/ Heterogeneous intraconal mass, eyeball
displacement, medial rectus and optic
nerve involvement
Hemangioma
Pseudotumor
Rhabdomyosarcoma
BCVA Z best-corrected visual acuity; CF Z counting finger; F Z female; L Z left; LP Z light perception; M Z male; R Z right.
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Figure 1 Case 4. (A) Facial appearance at initial examination reveals a protruding mass with severe displacement of globe and
marked strabismus. (B) Sagittal computed tomographic image shows well-enhanced heterogeneous soft-tissue mass in the inferior
orbit. (C) A well-circumscribed tumor measuring 5  3.5  1.5 cm3. (D) Good prognosis after surgical treatment and adjuvant
radiotherapy.
Orbital hemangiopericytoma in an Asian population 359figures and apoptosis were described as having some
malignant features.
Immunochemical studies in five of our six cases demon-
strated CD34 reactivity (Fig. 4B), and only Case 6 showed
negative CD34 but positive Vimentin and CD99 reactivity.
However, cytokeratin, leukocyte common antigen (LCA),
epithelial membrane antigen (EMA), glial fibrillary acidic
protein (GFAP), and smooth muscle actin were not detected
in any patient.
Summaries of treatments and outcomes during follow-
up periods are also listed in Table 2. Each patientFigure 2 Ultrasonography of Case 2 showed low to moderate
echogenicity.underwent at least one operation and had regular follow-
up. Only two cases (Cases 1 and 5) responded well to
surgical treatment alone and have been doing well without
recurrence or metastasis for at least 4 years. The other
four patients had tumor excision combined with radio-
therapy. Case 4 began intensity-modulated radiation
therapy (IMRT) course immediately following the surgery
with the goal of minimizing local recurrence. No sign of
recurrence was found during 4 years of follow-up. Three
patients (Cases 2, 3, and 6) received IMRT for therapeutic
reasons after recurrences. In Patient 2, recurrence
occurred 6 years after the surgery and the patient
received IMRT after the second operation including total
tumor excision with enucleation. The patient has been
doing well since the last operation.
Patient 3 had three surgeries due to two recurrences (in
2005 and 2006). The second and third operations were per-
formed by an experienced neurosurgeon. However, subtotal
excision (in 2006 and 2007) with adjuvant radiotherapy was
performed after recurrences because total removal of the
lesion was not possible. There has not been another recur-
rence for the past 4 years since the last operation.
Patient 6, who had the poorest outcome, having three
orbital recurrences and multiple metastases of the lung and
liver, had also received radiotherapy along with multiple
surgical excisions. Two of the three orbital surgeries were
performed by oculoplastic surgeon through orbitotomy with
tumor excision, and the other one was performed by
a neurosurgeon undergoing Simpson grade IV surgery. Two
courses of IMRT were given for the second and third orbital
recurrences. After the third surgery followed by
Figure 3 Case 5. (A) Coronal computed tomographic image shows heterogeneous mass in the superior orbit. (B) Histopathological
appearance shows staghorn-configured, thin-walled branching vessels (hematoxylineeosin; 200).
360 C.-H. Hsu et al.radiotherapy, the orbital tumor was latent for 3 years.
However, in 2009, another orbital recurrence was discov-
ered via imaging studies, but only IMRTwas performed. The
residual lesion has been stable since. Regarding the
metastases, pulmonary lesions were found 5 years after
primary tumor was diagnosed and therefore three video-
assisted thoracoscopic surgeries were performed in 2008,
2009, and 2010. Liver metastasis occurred in 2010, and an
atypical hepatectomy was performed as the surgical
treatment. The patient is still under intensive follow-up for
the control of this malignant disease.Discussion
Hemangiopericytoma, a rare vascular tumor arising from
pericytes, which are of mesenchymal origin, was first
described about 65 years ago.1 Pelvic retroperitoneal
spaces and soft tissues of the neck, extremities, trunk, and
paraspinal areas are the most common sites of tumor
growth.9 Orbital involvement is rare.2 It primarily affects
adults with the median age ranging from 42 to 45 years, as
found in two large series.5,6 Our study was similar to
previous studies; ages ranged from 30 to 62 years, with
a median of 44 years. Most of the orbital tumors occur
unilaterally without apparent predisposition for race or
sex,2 although in males twice incidence has been reported
by Croxatto and Font.5 However, in this series, five of the
six cases were females. Because of the limiting case
number, it is difficult to explain the influence of sex pref-
erence on disease incidence compared to previous studies.
It may be the racial difference between the Caucasian and
Asian people. Further case collections and studies are
needed to explain the finding.
Orbital hemangiopericytoma almost always manifests
with slowly increasing proptosis with or without associated
pain and impaired visual acuity. Croxatto and Font5 re-
ported that 21% and 17% of their patients had pain and
visual impairment, respectively, at initial examination.
Among this six cases, only one patient (16.7%) had pain at
initial presentation and four patients (66.7%) complained
blurring or loss of vision. Among the four patients whosuffered from severely decreased visual acuity, there was
no obvious association with sex, duration prior to diagnosis,
or size of the tumors. CT images showed compression of the
optic nerve in three cases (50%). The cause of the impaired
vision seems to be the location of the lesion. As presented
in this study, other manifestations of a space-occupying
mass within the orbit may include extraocular motility
abnormalities with diplopia, displacement of the globe,
afferent pupillary defect, and congested vessels. The
majority of orbital hemangiopericytomas occur superiorly
in the orbit, as reported by Sullivan and associates,10 and
therefore downward displacement is common. A similar
result was also found in our series: four of the tumors
(66.7%) were at least partially located superiorly, one
(16.7%) had an inferiorly localized lesion (Fig. 1B), and the
other one (16.7%) had a medially placed tumor. In addition,
symptoms of eyelid swelling with blue or red discoloration
of the adnexa oculi were occasionally noted, but conges-
tion and edema of the conjunctivae or other soft tissue
might not be as severe as those seen in patients with
inflammatory pseudotumor.
Another clinical finding found in Patient 2 has seldom
been reported. A tumor-like lesion with pigmentation was
located around the macular area on the retina, which
caused shallow retinal detachment. The patient had not
received any examination until 10 years after first experi-
encing blurred vision. The tumor, located retrobulbarly,
displaced the eyeball anteroinferiorly and compressed the
globe. No sign of tumor invasion to the globe was found on
image studies or in histopathological examinations. The
change in the retina may be only due to the compressive
effects of the lesion.
In the Croxatto and Font series,5 the symptoms were
present for less than 1 year in the majority of their
patients. In this study, the symptoms were noted for not
more than 6 months in four of six patients (66.7%), which
are similar to those in previous studies.5 We think that
double vision or decreased visual acuity urged these four
patients to undergo further ophthalmic examinations.
Only Cases 1 and 2 presented symptoms 2 and 10 years
prior to diagnosis, respectively. No visual disturbance and
only cosmetic eye protrusion make Patient 1 unaware of
Table 2 Summary of pathological findings, treatment, and outcome.
No. Histologic features (cells) Histologic features
(tumor type)
Histologic features
(vessel appearance)
Immunohistochemistry Treatments Outcome
1 Spindle, bland appearing Vascular tumor Staghorn vessels CD 34 (þ)
Cytokeratin ()
LCA ()
/ Tumor excision (2001) Doing well 9.5 y postoperatively
2 Bland with vesicular chromatin Vascular tumor Staghorn vessels CD34 (þ)
EMA ()
GFAP ()
/ Tumor excision (2001)
/ Total tumor excision with
enucleation (2008)
/ IMRT (2008)
Recurrence (2008)
Doing well 2 y post radiotherapy
3 Ovoid nuclei, inconspicuous
nucleoli, and ill-defined
cytoplasm, occasional mitosis
Vascular tumor Staghorn vessels CD34 (þ)
Cytokeratin ()
LCA ()
/ Tumor excision (2003)
/ Total tumor excision (2005)
/ Subtotal excision (2006)
/ IMRT (2006)
Recurrence (2005, 2006)
Doing well 4 y post radiotherapy
4 Monotonous spindle, arranged in
fascicular pattern Occasional
necrosis
Hypercellular tumor Staghorn vessels CD34 (þ) / Tumor excision (2006)
/ IMRT (2006)
Doing well 4 y postoperatively
5 Oval to spindle; vesicular nuclei,
indistinct nucleoli, indistinct cell
borders, and low mitotic rate
Vascular tumor Staghorn vessels CD34 (þ)
GFAP ()
/ Tumor excision (2006) Doing well 4 y postoperatively
6 Vesicular nuclei, indistinct
nucleoli; frequent mitotic figures
and apoptosis
Moderate vascularity
tumor
Staghorn vessels Vimentin (þ)
CD99 (þ)
CD34 ()
EMA ()
LCA ()
Cytokeratin ()
/ Tumor excision (2003,
2005 and 2006)
/ IMRT (2006)
/ Evisceration (2007)
/ VATS: wedge resection
(2008, 2009)
/ IMRT (2009)
/ VATS: Lobectomy (2010)
/ Hepatectomy (2010)
Recurrence (2005, 2006, 2009)
Metastasis
Lung (2008)
Liver (2010)
Still under intensive follow-up
EMA Z epithelial membrane antigen; GFAP Z glial fibrillary acidic protein; IMRT Z intensity-modulated radiation therapy; LCA Z leukocyte common antigen; VATS Z video-assisted
thoracoscopic surgery.
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Figure 4 Case 4. (A) Histopathological appearance shows tumor cells arranged in fascicular pattern, interrupted by slit-like
staghorn vessels (hematoxylineeosin; 200). (B) Immunohistochemical preparation reveals spindle cells with diffuse immunore-
activity to CD34 (200).
362 C.-H. Hsu et al.searching for medical help. However, in Case 2, the patient
came for help only after loss of vision due to personal
reason. In Croxatto and Font’s report, most of the tumors
are circumscribed and range from 1.5 to 5.5 cm in diam-
eter. Similar tumor sizes were also found in our series
(ranging from 1.2 to 6 cm). However, neuro-ophthalmologic
findings, such as abnormal pupil light reflex, do not seem to
show a direct correlation to the size of orbital mass.
In previous study, ultrasonography usually showed
a well-delineated round or oval lesion within the orbit with
low to medium internal reflectivity. Mostly, the structure of
the tumor is irregular, with solid and cystic components.4
As Karcioglu et al concluded, although echography is
helpful in delineating the masses, it does not offer any
specific information for the diagnosis of hemangioper-
icytoma. On the other hand, cystic changes may even be
misleading when formulating a differential diagnosis.6
Therefore, ultrasonography has not been part of our
routine image examinations for evaluating orbital masses
within the past 10 years. This is why only two of our patients
received B-scan echography prior to treatment (Fig. 2), but
all six cases received CT. CT images of the orbital heman-
giopericytoma tend to manifest as circumscribed, homoge-
neous masses, which enhanced with contrast medium.5,6 In
this study, the tumors enhanced with contrast in patients
who had contrast CT study (Fig. 1B). CT appears to be
a better diagnostic image examination for the tumors.
However, in our series of six cases, hemangiopericytoma
was considered among the initial list of differential diag-
noses only in one case after CT was completed. Therefore,
we concluded that image studies (including CT imaging and
ultrasonography) alone may not be enough for the diagnosis
of hemangiopericytoma.
The definite diagnosis of hemangiopericytoma usually
depends on histopathological examination. Hemangioper-
icytoma typically appears as a mixture of spindle-shaped
tumor cells with oval nuclei and scanty cytoplasms mixed
with a network of thin-walled blood vessels or sinusoid-like
spaces. This pattern is described as staghorn appearance.9
In this study, all cases were reported as vascular tumors and
featured with branching “staghorn appearance” vessels
(Figs. 3B and 4A). In congruence with the previous obser-
vations, tumor cells portrayed spindle-shaped and oval
nuclei in three of our pathological reports. Recently, somepathologists stated that orbital hemangiopericytoma and
some cases previously designated as fibrous histiocytoma,
giant cell angiofibroma of orbit, and solitary fibrous tumor
have overlapping morphologic and immunohistochemical
features and should be designated as solitary fibrous
tumor.11 In addition, Gengler and Guillou12 also suggested
orbital hemangiopericytoma and fibrous histiocytoma, giant
cell angiofibroma of orbit, and solitary fibrous tumor
designated as a solitary fibrous tumor spectrum from
histopathological point of view. However, in publications
listed in Pubmed, the terms “hemangiopericytoma” or
“cellular variant of solitary fibrous tumor” have frequently
been used as the same disease entity in recent publications.
In this study, we still use “orbital hemangiopericytoma” as
the diagnostic term.
Hemangiopericytomas may present with a variety of
malignant-appearing forms, such as cellular pleomorphism,
abnormal mitotic figures, zones of necrosis, and hemor-
rhage.5 However, the malignant potential of the tumor
cannot be determined on the basis of histopathological
findings only. As reported in previous studies, a markedly
pleomorphic cellular appearance can be associated with
a benign course, whereas in other studies, benign-
appearing spindle cells may result in metastasis.5 In our
series, two (Cases 1 and 2) of the six pathological reports
described the cells as bland in appearance and another
two (Case 3 and 5) with a low mitotic rate. Only two
reports (Cases 4 and 6) revealed malignant features. In
Patient 4, occasional necrosis was described, but the
patient was given a good prognosis after surgical excision.
However, among the three patients with recurrence (Cases
2, 3, and 6), Case 6 had been reported to have frequent
mitotic figures and apoptosis. Nevertheless, Patients 2
and 3 had only “bland cells with low mitotic rate.” In
other words, among the four cases with histopathological
benign-appearing spindle cells, 50% had poor prognosis of
recurrence. However, half of the two patients whose
histopathological reports revealed malignant featured cells
still presented a benign course. It shows that histopatho-
logical findings are necessary to diagnose this disease,
although clinical findings are most important to predict the
prognosis. As mentioned above, it is difficult to predict the
malignant potential of hemangiopericytoma by histopath-
ological findings alone. Many patients who develop
Orbital hemangiopericytoma in an Asian population 363recurrence and metastases exhibit variable histopatholog-
ical features including malignant as well as benign features
at the time of their initial tissue diagnosis.13 Croxatto and
Font5 reported 30% and 15% local recurrence and metastasis
rates, respectively. In our series, half of the cases (50%) had
recurrence including one (16.7%) with multiple metastasis.
The other half have been doing well thus far.
Hemangiopericytomas have a specific immunohisto-
chemical profile, which aids in their diagnosis. The tumor
cells react against vimentin and, in most cases, against
CD34, but they lack immunoreactivity for EMA. They also
lack immunoreactivity for cytokeratins (markers for epithe-
lial malignancies), LCA (indicator of the hematolymphoid
nature of a tumor), GFAP (markers for cells of central
nervous system), and carcinoembryonic antigen.13,14 In
this study, five cases were CD 34 positive (Fig. 4B), and
one case was vimentin and CD 99 positive. Cytokeratin,
LCA, EMA, and GFAP were negative in all tumor speci-
mens (Table 2).
The best treatment for hemangiopericytoma is total
excision of the tumor, as it is usually well circumscribed, and
complete excision of initial tumor appears to have the
greatest impact on subsequent tumor behavior. Incomplete
excision is associated with a higher risk of local recurrence
and distant metastasis. In general, radiotherapy has been
used only when the lesion was incompletely excised.15 In
addition, proton beam therapy had been shown to be
effective in controlling recurrent orbital hemangioper-
icytoma in Gear et al’s study.16 In our series, four of the six
patients received radiotherapy. In Case 4, IMRT was per-
formed as an adjuvant therapy immediately after the first
surgical treatment, and the patient has been doing well
without recurrence or metastasis since the surgery (Fig. 1D).
The other three patients received radiotherapy as a thera-
peutic treatment for local recurrence,with good response. In
a previous study, one case of orbital hemangiopericytoma
has been reported to recur as long as 33 years later,17 indi-
cating that an extended follow-up is required.
In summary, our study of orbital hemangiopericytoma
coincides with the conclusions from previous studies that
both clinical and histopathological findings are important
for diagnosing and evaluating the treatment outcomes.
Immunohistochemistry is a useful adjunct to histopatho-
logical diagnosis, and histopathological features alone
cannot predict the biologic behavior regarding the malig-
nant potential of the tumor. Ultrasonography and CT both
are helpful in delineating these orbital masses and for
follow-up, but they do not offer any insights for the diag-
nosis of hemangiopericytomas. Surgical excision remains
the treatment of choice for this neoplastic disease, andradiotherapy can be an effective adjuvant treatment for
recurrence.References
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